Genovis AB (publ.) Statistics
Total Valuation
STO:GENO has a market cap or net worth of SEK 1.35 billion. The enterprise value is 1.27 billion.
| Market Cap | 1.35B |
| Enterprise Value | 1.27B |
Important Dates
The last earnings date was Friday, November 7, 2025.
| Earnings Date | Nov 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:GENO has 66.06 million shares outstanding. The number of shares has increased by 0.24% in one year.
| Current Share Class | 66.06M |
| Shares Outstanding | 66.06M |
| Shares Change (YoY) | +0.24% |
| Shares Change (QoQ) | +0.91% |
| Owned by Insiders (%) | 14.60% |
| Owned by Institutions (%) | 15.39% |
| Float | 56.42M |
Valuation Ratios
The trailing PE ratio is 63.04 and the forward PE ratio is 44.16. STO:GENO's PEG ratio is 1.18.
| PE Ratio | 63.04 |
| Forward PE | 44.16 |
| PS Ratio | 11.48 |
| PB Ratio | 5.13 |
| P/TBV Ratio | 7.38 |
| P/FCF Ratio | 39.48 |
| P/OCF Ratio | 38.91 |
| PEG Ratio | 1.18 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 32.65, with an EV/FCF ratio of 37.09.
| EV / Earnings | 59.91 |
| EV / Sales | 10.79 |
| EV / EBITDA | 32.65 |
| EV / EBIT | 45.60 |
| EV / FCF | 37.09 |
Financial Position
The company has a current ratio of 10.78, with a Debt / Equity ratio of 0.28.
| Current Ratio | 10.78 |
| Quick Ratio | 8.61 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 2.27 |
| Debt / FCF | 2.14 |
| Interest Coverage | 4.60 |
Financial Efficiency
Return on equity (ROE) is 8.72% and return on invested capital (ROIC) is 4.16%.
| Return on Equity (ROE) | 8.72% |
| Return on Assets (ROA) | 3.86% |
| Return on Invested Capital (ROIC) | 4.16% |
| Return on Capital Employed (ROCE) | 6.08% |
| Revenue Per Employee | 3.27M |
| Profits Per Employee | 588,444 |
| Employee Count | 32 |
| Asset Turnover | 0.34 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, STO:GENO has paid 3.53 million in taxes.
| Income Tax | 3.53M |
| Effective Tax Rate | 14.27% |
Stock Price Statistics
The stock price has decreased by -16.70% in the last 52 weeks. The beta is 2.12, so STO:GENO's price volatility has been higher than the market average.
| Beta (5Y) | 2.12 |
| 52-Week Price Change | -16.70% |
| 50-Day Moving Average | 21.80 |
| 200-Day Moving Average | 23.80 |
| Relative Strength Index (RSI) | 45.15 |
| Average Volume (20 Days) | 162,615 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:GENO had revenue of SEK 117.66 million and earned 21.18 million in profits. Earnings per share was 0.32.
| Revenue | 117.66M |
| Gross Profit | 104.92M |
| Operating Income | 21.15M |
| Pretax Income | 24.71M |
| Net Income | 21.18M |
| EBITDA | 25.73M |
| EBIT | 21.15M |
| Earnings Per Share (EPS) | 0.32 |
Balance Sheet
The company has 154.89 million in cash and 73.07 million in debt, giving a net cash position of 81.82 million or 1.24 per share.
| Cash & Cash Equivalents | 154.89M |
| Total Debt | 73.07M |
| Net Cash | 81.82M |
| Net Cash Per Share | 1.24 |
| Equity (Book Value) | 263.53M |
| Book Value Per Share | 3.99 |
| Working Capital | 175.80M |
Cash Flow
In the last 12 months, operating cash flow was 34.72 million and capital expenditures -504,000, giving a free cash flow of 34.22 million.
| Operating Cash Flow | 34.72M |
| Capital Expenditures | -504,000 |
| Free Cash Flow | 34.22M |
| FCF Per Share | 0.52 |
Margins
Gross margin is 89.17%, with operating and profit margins of 17.97% and 18.00%.
| Gross Margin | 89.17% |
| Operating Margin | 17.97% |
| Pretax Margin | 21.00% |
| Profit Margin | 18.00% |
| EBITDA Margin | 21.86% |
| EBIT Margin | 17.97% |
| FCF Margin | 29.08% |
Dividends & Yields
STO:GENO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.24% |
| Shareholder Yield | -0.24% |
| Earnings Yield | 1.57% |
| FCF Yield | 2.53% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 4, 2012. It was a reverse split with a ratio of 0.1.
| Last Split Date | Apr 4, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |